Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests
Company Aims to Make Routine Health Testing Convenient, Affordable and Actionable
Led by Former Illumina Executive Jeff Hawkins as Chief Executive Officer
Company Expands Leadership Team with the Addition of Katherine Atkinson as Chief Commercial Off... Diagnostics, Venture Capital, Personnel Truvian Sciences
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Venture Capital